Delivery Order SPE2DB22D3501-SPE2DB25FXD29
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,059.35 to AmerisourceBergen Drug Corp for Hemabate 250 MCG/ML ampules, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $2,119.75 delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/mL ampules, with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.85 to AmerisourceBergen Drug Corp for the supply of Hemabate 250 micrograms per milliliter in ampule format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Hemabate 250 micrograms per milliliter in ampule form. This firm fixed-price delivery order, valued at $2,119.75, is non-set-aside and scheduled for completion by September 29, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,030.16 firm fixed-price delivery order is for the supply of HEMABATE 250 MCG/ML AMPULML, a medication used in various medical treatments. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,666.41, is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a $5,321.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp to provide HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. This award was issued under the DLA Troop Support Medical Indefinite Delivery Contract, which has a potential value of up to $999,999,999 for delivery of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of HEMABATE 250 MCG/ML AMPULML, a prescription medication. The firm-fixed-price contract has a ceiling value of $7,484.47 and a period of performance through August 29, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, with ID SPE2DB20D3104|SPE2DB21FW0E5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,511.36, is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is the prime contractor for this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HEMABATE 250 MCG/ML ampules, with a ceiling value of $4,239.50 under a firm fixed-price contract structure. This non-set-aside award was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. HEMABATE (carboprost tromethamine) is a pharmaceutical product used in obstetric and gynecological applications. The performance location is AmerisourceBergen Drug Corp's corporate...